California introduces the “C.U.R.L. Act” to ban certain Hair Relaxers Ingredients

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Jennifer Porter, BA Psychology, MBA – President & CEO

Having started at Focal Point Research in 2011, Jenn has been fully engaged in the company and since day one, has leveraged her MBA and interest in the regulated products industries to grow her passion for the business and services offered.

Jenn has excelled at building on initial conversations with a variety of companies from all industries seeking regulatory and quality assurance services. She has developed strong relationships with each client, offering each one a unique opportunity to have the Focal Point Research team help them develop successful strategies and bring products to market, while ensuring their compliance needs are being fulfilled.

Jenn has not only been a leader internally, but a key contact for all clients and in 2021, Jenn was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

Jennifer balances her career by honouring her wanderlust, spending her leisure time golfing, and enjoying the outdoors with her loving dog.

The California Legislature has passed a new bill, SB 236, also known as the Combating Unsafe Relaxers (C.U.R.L) Act. This bill prohibits any person from manufacturing, distributing, selling, or offering for sale in California any hair relaxer product that contains a specified list of intentionally added ingredients:

Formaldehyde (CAS no. 50-00-0)
Isobutylparaben (CAS no. 4247-02-3)
Isopropylparaben (CAS no. 4191-73-5)
Cyclohexylamine (CAS no. 108-91-8)
Cyclotetrasiloxane (CAS no. 556-67-2)
Diethanolamine perfluorooctane sulfonate (CAS no. 70225-14-8)
Dibutyl phthalate (CAS no. 84-74-2)
Diethylhexyl phthalate (CAS no. 117-81-7)
Lily aldehyde (CAS no. 80-54-6)

Key Provisions of the Bill:

The Bill requires the Department of Toxic Substances Control to adopt regulations on or before January 1, 2030
The Department of Toxic Substances Control (DTSC) would be responsible for implementing and enforcing the new rules.
The Bill requires DTSC to:

publish appropriate third-party accreditations for laboratories to test for the specified ingredients.
Publish a list of accepted testing methods for those ingredients.

The Bill authorizes the department to:

request, and would require a manufacturer of a hair relaxer product to provide upon request, documentation, including test results, to demonstrate compliance
test hair relaxer products in order to support enforcement of the provisions
issue notices of violation and access administrative or civil penalties

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

California introduces the “C.U.R.L. Act” to ban certain Hair Relaxers Ingredients

Recent Posts

Recent Comments

Archives

Categories